GLPwatch

Liraglutide-induced acute pancreatitis.

J Assoc Physicians India · 2014

Last updated 2026-05-28

A 51-year-old woman with Type 2 Diabetes took the GLP-1 drug liraglutide for 8 weeks before developing severe abdominal pain, nausea, and vomiting. Tests confirmed acute pancreatitis, and she was hospitalized. After stopping liraglutide, her symptoms improved, and her pancreatic enzyme levels returned to normal.

AI summary of the abstract below.

JournalJ Assoc Physicians India, 2014
Citations12
Relative citation ratio0.47
NIH percentile28
Molecules liraglutide

Abstract

An obese lady of 51 year with Type 2 Diabetes Mellitus for 13 years was prescribed Liraglutide, a glucagon like peptide (GLP-1) analogue (Victoza) for glycaemic control and reduction of weight. She was on gliclazide and Insulin prior to initiation of Liraglutide. Eight weeks after initiation of GLP -1 analogue, she developed severe abdominal pain, nausea and vomiting. She was admitted to a private hospital and evaluated. Biochemical tests and CT scan revealed presence of pancreatitis and she was treated for acute pancreatitis. Liraglutide was withdrawn and symptoms subsided. Subsequent follow-up showed that pancreatic enzyme levels were normal.

Verbatim abstract via PubMed 25327099 ↗

Related research